194 related articles for article (PubMed ID: 35503721)
1. The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stress.
Liu Y; Feng J; Yuan K; Wu Z; Hu L; Lu Y; Li K; Guo J; Chen J; Ma C; Pang X
Elife; 2022 May; 11():. PubMed ID: 35503721
[TBL] [Abstract][Full Text] [Related]
2. The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapy.
Fabre MS; Stanton NM; Slatter TL; Lee S; Senanayake D; Gordon RMA; Castro ML; Rowe MR; Taha A; Royds JA; Hung N; Melnick AM; McConnell MJ
PLoS One; 2020; 15(4):e0231470. PubMed ID: 32320427
[TBL] [Abstract][Full Text] [Related]
3. BCL6 confers KRAS-mutant non-small-cell lung cancer resistance to BET inhibitors.
Guo J; Liu Y; Lv J; Zou B; Chen Z; Li K; Feng J; Cai Z; Wei L; Liu M; Pang X
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33393503
[TBL] [Abstract][Full Text] [Related]
4. Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cells.
Ujvari D; Nagy N; Madapura HS; Kallas T; Kröhnke MCL; Stenke L; Klein E; Salamon D
Biochem Biophys Res Commun; 2018 Apr; 498(3):502-508. PubMed ID: 29510136
[TBL] [Abstract][Full Text] [Related]
5. Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo.
Richter A; Sender S; Lenz A; Schwarz R; Hinz B; Knuebel G; Sekora A; Murua Escobar H; Junghanss C; Roolf C
BMC Cancer; 2020 Mar; 20(1):184. PubMed ID: 32131762
[TBL] [Abstract][Full Text] [Related]
6. BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress.
Fernando TM; Marullo R; Pera Gresely B; Phillip JM; Yang SN; Lundell-Smith G; Torregroza I; Ahn H; Evans T; Győrffy B; Privé GG; Hirano M; Melnick AM; Cerchietti L
Cancer Discov; 2019 May; 9(5):662-679. PubMed ID: 30777872
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-specific protease 14 regulates ovarian cancer cisplatin-resistance by stabilizing BCL6 oncoprotein.
Shen J; Hong L; Chen L
Biochem Biophys Res Commun; 2020 Apr; 524(3):683-688. PubMed ID: 32033748
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response.
Tahara K; Takizawa M; Yamane A; Osaki Y; Ishizaki T; Mitsui T; Yokohama A; Saitoh T; Tsukamoto N; Matsumoto M; Murakami H; Nojima Y; Handa H
Cancer Sci; 2017 Aug; 108(8):1556-1564. PubMed ID: 28544233
[TBL] [Abstract][Full Text] [Related]
9. BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells.
Ranuncolo SM; Polo JM; Melnick A
Blood Cells Mol Dis; 2008; 41(1):95-9. PubMed ID: 18346918
[TBL] [Abstract][Full Text] [Related]
10. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival.
Lu X; Fernando TM; Lossos C; Yusufova N; Liu F; Fontán L; Durant M; Geng H; Melnick J; Luo Y; Vega F; Moy V; Inghirami G; Nimer S; Melnick AM; Lossos IS
Blood; 2018 Nov; 132(19):2026-2039. PubMed ID: 30082494
[TBL] [Abstract][Full Text] [Related]
11. Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells.
Phan RT; Saito M; Kitagawa Y; Means AR; Dalla-Favera R
Nat Immunol; 2007 Oct; 8(10):1132-9. PubMed ID: 17828269
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal negative regulation between the tumor suppressor protein p53 and B cell CLL/lymphoma 6 (BCL6) via control of caspase-1 expression.
Kim MK; Song JY; Koh DI; Kim JY; Hatano M; Jeon BN; Kim MY; Cho SY; Kim KS; Hur MW
J Biol Chem; 2019 Jan; 294(1):299-313. PubMed ID: 30409904
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis.
Xiang T; Tang J; Li L; Peng W; Du Z; Wang X; Li Q; Xu H; Xiong L; Xu C; Le X; Wei X; Yu F; Li S; Xiao Q; Luo B; Xiang X; Huang A; Lin Y; Ren G; Tao Q
Theranostics; 2019; 9(26):8182-8195. PubMed ID: 31754389
[TBL] [Abstract][Full Text] [Related]
14. BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells.
Kurosu T; Fukuda T; Miki T; Miura O
Oncogene; 2003 Jul; 22(29):4459-68. PubMed ID: 12881702
[TBL] [Abstract][Full Text] [Related]
15. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.
Dupont T; Yang SN; Patel J; Hatzi K; Malik A; Tam W; Martin P; Leonard J; Melnick A; Cerchietti L
Oncotarget; 2016 Jan; 7(3):3520-32. PubMed ID: 26657288
[TBL] [Abstract][Full Text] [Related]
16. An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer.
Sultan M; Nearing JT; Brown JM; Huynh TT; Cruickshank BM; Lamoureaux E; Vidovic D; Dahn ML; Fernando W; Coyle KM; Giacomantonio CA; Langille MGI; Marcato P
Mol Oncol; 2021 Aug; 15(8):2046-2064. PubMed ID: 33932086
[TBL] [Abstract][Full Text] [Related]
17. The Expanding Role of the BCL6 Oncoprotein as a Cancer Therapeutic Target.
Cardenas MG; Oswald E; Yu W; Xue F; MacKerell AD; Melnick AM
Clin Cancer Res; 2017 Feb; 23(4):885-893. PubMed ID: 27881582
[TBL] [Abstract][Full Text] [Related]
18. The feedback loop of LITAF and BCL6 is involved in regulating apoptosis in B cell non-Hodgkin's-lymphoma.
Shi Y; Kuai Y; Lei L; Weng Y; Berberich-Siebelt F; Zhang X; Wang J; Zhou Y; Jiang X; Ren G; Pan H; Mao Z; Zhou R
Oncotarget; 2016 Nov; 7(47):77444-77456. PubMed ID: 27764808
[TBL] [Abstract][Full Text] [Related]
19. Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer.
Wu M; Xie J; Xing Y; Zhang L; Chen H; Tang B; Zhou M; Lv S; Huang D; Jian S; Zhou C; Liu M; Guo W; Chen Y; Yi Z
Int J Biol Sci; 2024; 20(2):486-501. PubMed ID: 38169532
[TBL] [Abstract][Full Text] [Related]
20. BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells.
Kawabata KC; Zong H; Meydan C; Wyman S; Wouters BJ; Sugita M; Goswami S; Albert M; Yip W; Roboz GJ; Chen Z; Delwel R; Carroll M; Mason CE; Melnick A; Guzman ML
Blood; 2021 Feb; 137(6):812-825. PubMed ID: 32911532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
